Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dura begins clinical program on Budesonide Spiros

Oct. 29, 1999

Nortran's intractable cough treatment completes safety trial

Oct. 29, 1999

Dainippon Ink & Chemicals begins clinical testing of allergy drug

Oct. 28, 1999

Schering-Plough files for marketing clearance for desloratadine on two continents

Oct. 27, 1999

Sheffield Pharmaceuticals completes inhaled steroid agreement with Elan

Oct. 26, 1999

Potent new methylprednisolone and betamethasone derivatives show promise for asthma

Oct. 20, 1999

Glaxo Wellcome's Advair Diskus NDA to be reviewed at late November advisory committee meeting

Oct. 19, 1999

Dura and Spiros initiate pivotal clinical program for Beclomethasone Spiros

Oct. 18, 1999

Inflazyme to commence phase Ib studies with new oral asthma therapy

Oct. 18, 1999

Anti-IgE MAb improves quality of life in allergy sufferers

Oct. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...